Celldex Therapeutics | CLDX - Trade Debtors

Stock Price
29.37
Daily Change
-0.17 -0.58%
Monthly
23.61%
Yearly
37.69%
Q1 Forecast
29.17

Celldex Therapeutics reported $2.02M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Agenus USD 354K 53K Mar/2025
Amgen USD 9.57B 1.08B Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Celldex Therapeutics USD 2.02M 1.92M Dec/2025
Glaxosmithkline GBP 11.16B 3.46B Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Pfizer USD 18.12B 2.02B Sep/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 11.9B 460M Dec/2025